Compression anastomosis clip for gastrointestinal anastomosis

Table 1 Clinical data obtained from the patients (mean ± SD)

	Study group (n = 33)	Control group (n = 33)
Sex (M:F)	24:9	21:12
Age (yr)	57.0 ± 11.85	58.6 ± 13.23
Height (cm)	167.7 ± 7.54	166.4 ± 8.59
Body weight (kg)	61.7 ± 10.92	62.7 ± 7.49
BMI (kg/m2)	21.9 ± 3.13	22.7 ± 3.54
Albumin (g/L)	41.6 ± 4.44	39.9 ± 4.77
Hemoglobin (g/L)	125.8 ± 17.48	118.6 ± 16.34
Prealbumin (mg/L)	276.1 ± 105.74	301.9 ± 100.18

Table 2 Primary disease and distribution of patients

Dignosis	Study group	Control group	Total
Malignant
Gastric cancer	21	24	45
Gastric stump cancer	1	0	1
Reflux esophagitis	1	0	1
Anastomotic stenosis	1	1	2
Intestinal tumor	2	0	2
Total	26	25	51
Benign
Intestinal adhesion	3	2	5
Intestinal tumor	1	1	2
Peptic ulcer disease	1	3	4
Annular pancreas	1	0	1
Inflammatory bowel disease	1	2	3
Total	7	8	15

Table 3 Anastomotic site and operative procedure

Site	Study group	Control group	Total
Stomach-small bowel
Subtotal gastrectomy with a Billroth II reconstruction	12	11	23
Gastrojejunostomy	6	3	9
Total	18	14	32
Small bowel-small bowel
Total gastrectomy with a Roux-en-Y reconstruction	9	14	23
Enteroenterostomy	6	5	11
Total	15	19	34

Table 4 Recovery-related variables after operation (mean ± SD)

Variable	Study group	Control group	P
	(n = 33)	(n = 33)
Gases started (d)	4.3 ± 1.24	4.7 ± 1.28	0.230
Bowel movement (d)	5.7 ± 2.36	6.2 ± 2.53	0.407
Antibiotics stopped (d)	3.8 ± 0.74	4.0 ± 0.83	0.258
Duration of nasogastric drainage (d)	2.6 ± 0.98	2.8 ± 0.64	0.314
Start of oral intake (d)	4.8 ± 1.82	5.4 ± 1.69	0.174
Postoperative hospital duration (d)	14.9 ± 6.01	15.1 ± 8.35	0.946